HOOKIPA and Poolbeg update: Gilead to invest up to $8.75M in potential combination fundraise

HOOKIPA Pharma Inc.

Gilead intends to vote consistent with HOOKIPA board recommendation if a formal offer is made.
Gilead to participate in concurrent Fundraise up to $8.7495 million, consistent with existing obligations.
Discussions remain non-binding and non-exclusive; no assurance of a firm offer or transaction completion.
Update follows prior announcements on January 2 and January 7, 2025 regarding the potential combination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.